Cargando…

Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis

OBJECTIVE: This study aims to explore the clinicopathologic characteristics and prognostic factors of gastric cancer patients with metachronous ovarian metastasis. METHODS: Clinicopathologic data were collected from 63 post-operative gastric cancer patients with metachronous ovarian metastasis. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qiang, Pei, Wei, Zheng, Zhao-Xu, Bi, Jian-Jun, Yuan, Xing-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719191/
https://www.ncbi.nlm.nih.gov/pubmed/23882423
http://dx.doi.org/10.7497/j.issn.2095-3941.2013.02.004
_version_ 1782277872662085632
author Feng, Qiang
Pei, Wei
Zheng, Zhao-Xu
Bi, Jian-Jun
Yuan, Xing-Hua
author_facet Feng, Qiang
Pei, Wei
Zheng, Zhao-Xu
Bi, Jian-Jun
Yuan, Xing-Hua
author_sort Feng, Qiang
collection PubMed
description OBJECTIVE: This study aims to explore the clinicopathologic characteristics and prognostic factors of gastric cancer patients with metachronous ovarian metastasis. METHODS: Clinicopathologic data were collected from 63 post-operative gastric cancer patients with metachronous ovarian metastasis. The patients were admitted to the Cancer Institute and Hospital, Chinese Academy of Medical Science and Peking Union Medical College between January 1999 and December 2011. A log-rank test was conducted for survival analysis. Possible prognostic factors that affect survival were examined by univariate analysis. A Cox regression model was used for multivariate analysis. RESULTS: The incidence of ovarian metastasis was 3.4% with a mean age of 45 years. Up to 65.1% of the patients were pre-menopausal. The mean interval between ovarian metastasis and primary cancer was 16 months. Lowly differentiated carcinoma ranked first in the primary gastric cancers. The majority of lesions occurred in the serous membrane (87.3%). The metastatic sites included N(2-3) lymph nodes (68.3%), bilateral ovaries (85.7%), and peritoneal membrane (73%). Total resection of metastatic sites was performed (31.7%). The overall median survival was 13.6 months, whereas the overall 1-, 2-, and 3-year survival rates were 52.5%, 22.0%, and 9.8%, respectively. The 5-year survival rate was zero. Univariate analysis showed that the patient prognosis was correlated with metastatic peritoneal seeding, vascular tumor embolus, range of lesion excision, and mode of comprehensive treatment with adjuvant chemotherapy (P<0.05). Multivariate analysis indicated that metastatic peritoneal seeding was an independent prognostic factor for gastric cancer patients with ovarian metastasis (P<0.01). CONCLUSION: Effective control of peritoneal seeding—induced metastasis is important for improving the prognosis of gastric cancer patients with ovarian metastasis.
format Online
Article
Text
id pubmed-3719191
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Chinese Anti-Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-37191912013-07-23 Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis Feng, Qiang Pei, Wei Zheng, Zhao-Xu Bi, Jian-Jun Yuan, Xing-Hua Cancer Biol Med Original Article OBJECTIVE: This study aims to explore the clinicopathologic characteristics and prognostic factors of gastric cancer patients with metachronous ovarian metastasis. METHODS: Clinicopathologic data were collected from 63 post-operative gastric cancer patients with metachronous ovarian metastasis. The patients were admitted to the Cancer Institute and Hospital, Chinese Academy of Medical Science and Peking Union Medical College between January 1999 and December 2011. A log-rank test was conducted for survival analysis. Possible prognostic factors that affect survival were examined by univariate analysis. A Cox regression model was used for multivariate analysis. RESULTS: The incidence of ovarian metastasis was 3.4% with a mean age of 45 years. Up to 65.1% of the patients were pre-menopausal. The mean interval between ovarian metastasis and primary cancer was 16 months. Lowly differentiated carcinoma ranked first in the primary gastric cancers. The majority of lesions occurred in the serous membrane (87.3%). The metastatic sites included N(2-3) lymph nodes (68.3%), bilateral ovaries (85.7%), and peritoneal membrane (73%). Total resection of metastatic sites was performed (31.7%). The overall median survival was 13.6 months, whereas the overall 1-, 2-, and 3-year survival rates were 52.5%, 22.0%, and 9.8%, respectively. The 5-year survival rate was zero. Univariate analysis showed that the patient prognosis was correlated with metastatic peritoneal seeding, vascular tumor embolus, range of lesion excision, and mode of comprehensive treatment with adjuvant chemotherapy (P<0.05). Multivariate analysis indicated that metastatic peritoneal seeding was an independent prognostic factor for gastric cancer patients with ovarian metastasis (P<0.01). CONCLUSION: Effective control of peritoneal seeding—induced metastasis is important for improving the prognosis of gastric cancer patients with ovarian metastasis. Chinese Anti-Cancer Association 2013-06 /pmc/articles/PMC3719191/ /pubmed/23882423 http://dx.doi.org/10.7497/j.issn.2095-3941.2013.02.004 Text en 2013 Cancer Biology & Medicine This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Original Article
Feng, Qiang
Pei, Wei
Zheng, Zhao-Xu
Bi, Jian-Jun
Yuan, Xing-Hua
Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis
title Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis
title_full Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis
title_fullStr Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis
title_full_unstemmed Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis
title_short Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis
title_sort clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719191/
https://www.ncbi.nlm.nih.gov/pubmed/23882423
http://dx.doi.org/10.7497/j.issn.2095-3941.2013.02.004
work_keys_str_mv AT fengqiang clinicopathologiccharacteristicsandprognosticfactorsof63gastriccancerpatientswithmetachronousovarianmetastasis
AT peiwei clinicopathologiccharacteristicsandprognosticfactorsof63gastriccancerpatientswithmetachronousovarianmetastasis
AT zhengzhaoxu clinicopathologiccharacteristicsandprognosticfactorsof63gastriccancerpatientswithmetachronousovarianmetastasis
AT bijianjun clinicopathologiccharacteristicsandprognosticfactorsof63gastriccancerpatientswithmetachronousovarianmetastasis
AT yuanxinghua clinicopathologiccharacteristicsandprognosticfactorsof63gastriccancerpatientswithmetachronousovarianmetastasis